Eledon Pharmaceuticals, Inc.
ELDN
$1.59
$0.117.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.10M | 4.46M | 4.53M | 6.46M | 3.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.07M | 24.73M | 17.96M | 24.70M | 20.51M |
| Operating Income | -19.07M | -24.73M | -17.96M | -24.70M | -20.51M |
| Income Before Tax | -17.46M | -11.22M | -6.50M | -44.19M | 76.97M |
| Income Tax Expenses | -- | -- | -- | 431.00K | -- |
| Earnings from Continuing Operations | -17.46M | -11.22M | -6.50M | -44.62M | 76.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.46M | -11.22M | -6.50M | -44.62M | 76.97M |
| EBIT | -19.07M | -24.73M | -17.96M | -24.70M | -20.51M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.23 | -0.15 | -0.08 | -0.60 | 1.91 |
| Normalized Basic EPS | -0.14 | -0.09 | -0.05 | -0.40 | 0.92 |
| EPS Diluted | -0.23 | -0.15 | -0.08 | -0.60 | -0.28 |
| Normalized Diluted EPS | -0.14 | -0.09 | -0.05 | -0.40 | 0.87 |
| Average Basic Shares Outstanding | 77.27M | 77.16M | 77.13M | 69.85M | 52.06M |
| Average Diluted Shares Outstanding | 77.27M | 77.16M | 77.13M | 69.85M | 55.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |